These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
182 related articles for article (PubMed ID: 29441505)
21. The Willingness to Pay for a Quality Adjusted Life Year: A Review of the Empirical Literature. Ryen L; Svensson M Health Econ; 2015 Oct; 24(10):1289-1301. PubMed ID: 25070495 [TBL] [Abstract][Full Text] [Related]
22. Health-Related Quality of Life and Willingness to Pay per Quality-Adjusted Life-Year Threshold-A Study in Patients with Epilepsy in China. Gao L; Xia L; Pan SQ; Xiong T; Li SC Value Health Reg Issues; 2015 May; 6():89-97. PubMed ID: 29698200 [TBL] [Abstract][Full Text] [Related]
23. Estimating the willingness to pay for a quality-adjusted life year in Thailand: does the context of health gain matter? Thavorncharoensap M; Teerawattananon Y; Natanant S; Kulpeng W; Yothasamut J; Werayingyong P Clinicoecon Outcomes Res; 2013; 5():29-36. PubMed ID: 23345984 [TBL] [Abstract][Full Text] [Related]
24. Willingness to pay per quality-adjusted life year in a study of knee osteoarthritis. Byrne MM; O'malley K; Suarez-Almazor ME Med Decis Making; 2005; 25(6):655-66. PubMed ID: 16282216 [TBL] [Abstract][Full Text] [Related]
25. Examining Willingness-to-Pay and Zero Valuations for a Health Improvement with Logistic Regression. Mavrodi AG; Chatzopoulos SA; Aletras VH Inquiry; 2021; 58():469580211028102. PubMed ID: 34271848 [TBL] [Abstract][Full Text] [Related]
26. Exploring the willingness to pay for a quality-adjusted life-year in the state of Penang, Malaysia. Shafie AA; Lim YW; Chua GN; Hassali MA Clinicoecon Outcomes Res; 2014; 6():473-81. PubMed ID: 25364267 [TBL] [Abstract][Full Text] [Related]
27. Willingness to Pay for a Quality-Adjusted Life Year among Gastrointestinal Cancer Patients at a Tertiary Hospital of Vietnam, 2022. Tran BT; Tran TT; La NQ; Nguyen TTP; Nguyen MH; Huynh TMC; Vu HP Asian Pac J Cancer Prev; 2024 May; 25(5):1725-1735. PubMed ID: 38809645 [TBL] [Abstract][Full Text] [Related]
28. The Worth of a Quality-Adjusted Life-Year in Patients with Diabetes: An Investigation Study using a Willingness-to-Pay Method. Moradi N; Rashidian A; Nosratnejad S; Olyaeemanesh A; Zanganeh M; Zarei L Pharmacoecon Open; 2019 Sep; 3(3):311-319. PubMed ID: 30617954 [TBL] [Abstract][Full Text] [Related]
29. Willingness to pay for a quality-adjusted life year: a systematic review with meta-regression. Kouakou CRC; Poder TG Eur J Health Econ; 2022 Mar; 23(2):277-299. PubMed ID: 34417905 [TBL] [Abstract][Full Text] [Related]
30. Willingness to pay for a quality-adjusted life year: implications for societal health care resource allocation. King JT; Tsevat J; Lave JR; Roberts MS Med Decis Making; 2005; 25(6):667-77. PubMed ID: 16282217 [TBL] [Abstract][Full Text] [Related]
31. Informal out-of-pocket payments experience and individuals' willingness-to-pay for healthcare services in Greece. Giannouchos TV; Ukert B; Vozikis A; Steletou E; Souliotis K Health Policy; 2021 Jun; 125(6):693-700. PubMed ID: 33838935 [TBL] [Abstract][Full Text] [Related]
32. A systematic review on the direct approach to elicit the demand-side cost-effectiveness threshold: Implications for low- and middle-income countries. Nu Vu A; Hoang MV; Lindholm L; Sahlen KG; Nguyen CTT; Sun S PLoS One; 2024; 19(2):e0297450. PubMed ID: 38329955 [TBL] [Abstract][Full Text] [Related]
33. Estimating the cost-effectiveness threshold of advanced non-small cell lung cancer in China using mean opportunity cost and contingent valuation method. Peng Q; Yin Y; Liang M; Zhao M; Shao T; Tang Y; Mei Z; Li H; Tang W Cost Eff Resour Alloc; 2023 Nov; 21(1):80. PubMed ID: 37915053 [TBL] [Abstract][Full Text] [Related]
34. GET MORE, PAY MORE? An elaborate test of construct validity of willingness to pay per QALY estimates obtained through contingent valuation. Bobinac A; van Exel NJ; Rutten FF; Brouwer WB J Health Econ; 2012 Jan; 31(1):158-68. PubMed ID: 22018622 [TBL] [Abstract][Full Text] [Related]
35. Estimating the range of incremental cost-effectiveness thresholds for healthcare based on willingness to pay and GDP per capita: A systematic review. Iino H; Hashiguchi M; Hori S PLoS One; 2022; 17(4):e0266934. PubMed ID: 35421181 [TBL] [Abstract][Full Text] [Related]
36. Preferences for improvements in attributes associated with basal insulin: a time trade-off and willingness-to-pay survey of a diabetic and non-diabetic population in Sweden. Olofsson S; Norrlid H; Persson U J Med Econ; 2016 Oct; 19(10):945-58. PubMed ID: 27149402 [TBL] [Abstract][Full Text] [Related]
37. A cost-benefit analysis using contingent valuation techniques: a feasibility study in spinal surgery. Haefeli M; Elfering A; McIntosh E; Gray A; Sukthankar A; Boos N Value Health; 2008; 11(4):575-88. PubMed ID: 18179657 [TBL] [Abstract][Full Text] [Related]
38. Valuing a hypothetical cure for rheumatoid arthritis using the contingent valuation methodology: the patient perspective. Fautrel B; Clarke AE; Guillemin F; Adam V; St-Pierre Y; Panaritis T; Fortin PR; Menard HA; Donaldson C; Penrod JR J Rheumatol; 2005 Mar; 32(3):443-53. PubMed ID: 15742435 [TBL] [Abstract][Full Text] [Related]
39. Sample restrictions and the elicitation of a constant willingness to pay per quality adjusted life year. Nielsen JS; Gyrd-Hansen D; Kjaer T Health Econ; 2021 May; 30(5):923-931. PubMed ID: 33569834 [TBL] [Abstract][Full Text] [Related]
40. The value of a QALY towards the end of life and its determinants: Experimental evidence. Fischer B; Telser H; Zweifel P; von Wyl V; Beck K; Weber A Soc Sci Med; 2023 Jun; 326():115909. PubMed ID: 37121067 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]